X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
female (9) 9
index medicus (9) 9
male (8) 8
middle aged (8) 8
adult (7) 7
chemotherapy (6) 6
oncology (6) 6
hematology (5) 5
leukemia (5) 5
acute myelogenous leukemia (4) 4
adolescent (4) 4
aged (4) 4
bone marrow (4) 4
cancer (4) 4
further section · weitere sektionen (4) 4
leukemia, myeloid, acute - mortality (4) 4
relapse (4) 4
remission induction (4) 4
transplants & implants (4) 4
treatment outcome (4) 4
young adult (4) 4
acute myeloid leukemia (3) 3
acute myeloid-leukemia (3) 3
aged, 80 and over (3) 3
aml (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
clinical trials (3) 3
hematology, oncology and palliative medicine (3) 3
internal medicine (3) 3
kaplan-meier estimate (3) 3
leukemia, myeloid, acute - diagnosis (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - genetics (3) 3
medical prognosis (3) 3
mortality (3) 3
mutation (3) 3
mutations (3) 3
recurrence (3) 3
risk factors (3) 3
stem-cell transplantation (3) 3
trans-retinoic acid (3) 3
abridged index medicus (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
apl (2) 2
care and treatment (2) 2
cerebrospinal fluid (2) 2
cytarabine (2) 2
development and progression (2) 2
diagnosis (2) 2
disease-free survival (2) 2
drug dosages (2) 2
elderly-patients (2) 2
fms-like tyrosine kinase 3 - genetics (2) 2
fms-like tyrosine kinase 3 - metabolism (2) 2
general practice / family medicine (2) 2
germany (2) 2
health aspects (2) 2
hematopoietic stem cell transplantation (2) 2
hematopoietic stem cell transplantation - methods (2) 2
induction therapy (2) 2
leukemia, myeloid, acute - therapy (2) 2
leukemia, promyelocytic, acute - drug therapy (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
paper (2) 2
prognosis (2) 2
proportional hazards models (2) 2
stem cells (2) 2
studies (2) 2
survival (2) 2
survival analysis (2) 2
time factors (2) 2
transplantation, homologous (2) 2
1951 (1) 1
1st complete remission (1) 1
21 egypten oldtiden -332 f.kr (1) 1
acute promyelocytic leukemia (1) 1
adult patients (1) 1
aegyptologie (1) 1
age (1) 1
age factors (1) 1
aida (1) 1
alanine (1) 1
alanine transaminase (1) 1
alleles (1) 1
allgemeines (1) 1
allmän kulturhistoria: forntiden: egypten (1) 1
altered ligand peptide (1) 1
analysis (1) 1
anemia (1) 1
aniline compounds - blood (1) 1
aniline compounds - pharmacology (1) 1
aniline compounds - therapeutic use (1) 1
anthracyclines (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 8, pp. 1061 - 1075
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2000 - 2008
Journal Article
Der Internist, ISSN 0020-9554, 3/2019, Volume 60, Issue 3, pp. 257 - 272
Im April 2018 ist die Neuauflage der Onkopedia-Leitlinie zur akuten myeloischen Leukämie (AML) als Aktualisierung von Vorversionen aus den Jahren 2010 und 2017... 
Molecular targeted therapy | Nephrology | Gemtuzumab | General Practice / Family Medicine | Midostaurin | Internal Medicine | Medicine & Public Health | Hepatology | Gastroenterology | Risikostratifizierung | Cardiology | Zielgerichtete Therapie | Risk, stratification | CPX-351
Journal Article
European Journal of Haematology, ISSN 0902-4441, 12/2017, Volume 99, Issue 6, pp. 544 - 552
Journal Article
Journal Article
Leukemia Research, ISSN 0145-2126, 10/2019, Volume 85, p. 106197
The role of histone deacetylase inhibitors in the treatment of acute myeloid leukemia (AML) is not well characterized. The current study evaluated the safety... 
Panobinostat | AML | Idarubicin | Cytarabine | Acute myeloid leukemia
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 3/2006, Volume 55, Issue 3, pp. 268 - 276
Journal Article